Lindus Health, a company that conducts end-to-end clinical trials for the life sciences sector, announced it raised $55 million in Series B Funding.The round was led by Balderton Capital with participation from Visionaries Club…
Continue Reading
What You Should Know:
– Lindus Health, a company transforming the clinical trial landscape with its tech-first approach raises $55M in Series B funding round led by Balderton Capital, with participation from Visionaries Club and…
Continue Reading
Story follows beneath the quote from the extended video below
[embedded content]
“There’s very little need and this sounds cynical and I’m not really, I hope not, a very cynical person, but there really isn’t a…
Continue Reading
Cornerstone Robotics bags $70M Series C fundingSurgical robotics maker Cornerstone Robotics from Hong Kong has raised over $70 million in a Series C funding round led by EQT. It also received additional investment from…
Continue Reading
Noam Solomon, CEO at Immunai
For over a decade, we’ve heard about AI’s transformative potential in therapeutics (Tx), but where’s the evidence? Has it all been hype? Can AI still revolutionize Tx? Or is there…
Continue Reading
Can artificial intelligence improve clinical trial design? Despite their importance in medicine, over 40% of trials involve flawed protocols. We introduce and propose the development of application-specific language models (ASLMs) for clinical trial design…
Continue Reading
Dozens of health systems representing millions of patients across the United States are collaborating with the Truveta Genome Project, Regeneron Genetics Center and genomic sequencing company Illumina to sequence the exomes of their first…
Continue Reading
Michel van Harten M.D., CEO of myTomorrows
Muscular Dystrophy (MD) refers to a group of rare genetic conditions that cause progressive muscle weakness and degeneration in patients. Some forms of MD, such as Duchenne Muscular…
Continue Reading
Top News
Several health systems launch the Truveta Genome Project, which will create a database of genotypic and phenotypic information. The data will be collected by using leftover biospecimens from the routine lab tests of…
Continue Reading
Cornerstone Robotics (CSR), a surgical robotics company, announced it raised more than $70 million in Series C funding. EQT led the round with participation from Qiming Venture Partners, Alpha JWC Ventures, the Innovation and Technology…
Continue Reading
